PT Kedoya Adyaraya Tbk (RSGK.JK)
IDR 990.0
(-1.0%)
IDR 990.0
(-1.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -57.42 Billion IDR | 66.84% |
| 2022 | -173.16 Billion IDR | -59.41% |
| 2021 | -108.62 Billion IDR | -185.43% |
| 2020 | 127.15 Billion IDR | 1.93% |
| 2019 | 124.74 Billion IDR | 29.96% |
| 2018 | 95.98 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -72.05 Billion IDR | -25.48% |
| 2024 Q2 | -67.29 Billion IDR | 6.6% |
| 2024 Q3 | -22 Billion IDR | 67.3% |
| 2023 Q1 | -180.26 Billion IDR | -4.1% |
| 2023 Q4 | -57.42 Billion IDR | 12.09% |
| 2023 Q3 | -65.31 Billion IDR | 58.91% |
| 2023 FY | -57.42 Billion IDR | 66.84% |
| 2023 Q2 | -158.98 Billion IDR | 11.81% |
| 2022 Q2 | -128.51 Billion IDR | 17.12% |
| 2022 FY | -173.16 Billion IDR | -59.41% |
| 2022 Q4 | -173.16 Billion IDR | -50.78% |
| 2022 Q3 | -114.84 Billion IDR | 10.63% |
| 2022 Q1 | -155.06 Billion IDR | -42.75% |
| 2021 Q3 | -120.67 Billion IDR | 0.0% |
| 2021 FY | -108.62 Billion IDR | -185.43% |
| 2021 Q1 | 55.15 Billion IDR | -56.62% |
| 2021 Q2 | - IDR | -100.0% |
| 2021 Q4 | -108.62 Billion IDR | 9.98% |
| 2020 FY | 127.15 Billion IDR | 1.93% |
| 2020 Q4 | 127.15 Billion IDR | 0.0% |
| 2019 FY | 124.74 Billion IDR | 29.96% |
| 2018 FY | 95.98 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Bundamedik Tbk | 497.89 Billion IDR | 111.533% |
| PT Metro Healthcare Indonesia Tbk | 427.86 Billion IDR | 113.421% |
| PT Medikaloka Hermina Tbk | 1405.68 Billion IDR | 104.085% |
| PT Mitra Keluarga Karyasehat Tbk | -839.7 Billion IDR | 93.161% |
| PT Murni Sadar Tbk | 490.08 Billion IDR | 111.717% |
| PT Famon Awal Bros Sedaya Tbk | 252.54 Billion IDR | 122.738% |
| PT Royal Prima Tbk | -26.49 Billion IDR | -116.748% |
| PT Sarana Meditama Metropolitan Tbk | 834.93 Billion IDR | 106.878% |
| PT Siloam International Hospitals Tbk | -552.3 Billion IDR | 89.603% |
| PT Sejahteraraya Anugrahjaya Tbk | 1135.04 Billion IDR | 105.059% |